Search

Author/Creator Melis, M.

2. AF.85 SYNERGIC PHYTOTHERAPEUTIC COMPLEX NUTRITIONAL SUPPLEMENTATION IMPROVES LIVER FUNCTION AND LIPID METABOLISM CLINICAL PARAMETERS IN OBESES AND/OR METABOLIC SYNDROME PATIENTS, IN ASSOCIATION WITH A LOW-CALORIC DIET. (September 2021)

Authors:
Ben Yahia, M.; Melis, M.; Cambarau, G.; Melis, A.; Tumbarello, F.E.; Sanna, F.; Loviselli, A.; Velluzzi, F.; Serpe, R.
Journal:
Digestive and liver disease
Issue:
Volume 53(2021)Supplement 3
Page Start:
S176
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. (17th December 2015)

Authors:
Di Maio, V. C.; Cento, V.; Di Paolo, D.; Aragri, M.; De Leonardis, F.; Tontodonati, M.; Micheli, V.; Bellocchi, M. C.; Antonucci, F. P.; Bertoli, A.; Lenci, I.; Milana, M.; Gianserra, L.; Melis, M.; Di Biagio, A.; Sarrecchia, C.; Sarmati, L.; Landonio, S.; Francioso, S.; Lambiase, L.
Journal:
Journal of antimicrobial chemotherapy
Issue:
Volume 71:Number 3(2016:Mar.)
Page Start:
739
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. HCV resistance test guided retreatments after protease inhibitors failures can induce maximal efficacy rate in real-life. Issue 1 (16th February 2017)

Authors:
Cento, V.; Barbaliscia, S.; Lenci, I.; Ruggiero, T.; Masetti, C.; Magni, C.F.; Micheli, V.; Paolucci, S.; Troshina, Y.; Biliotti, E.; Milana, M.; Melis, M.; Teti, E.; Lambiase, L.; Menzaghi, B.; Nicolini, L.A.; Marenco, S.; Di Maio, V.C.; Aragri, M.; Pecchioli, A.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e53
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies. Issue 1 (16th February 2017)

Authors:
Di Maio, V.C.; Cento, V.; Lenci, I.; Aragri, M.; Barbaliscia, S.; Francioso, S.; Paolucci, S.; Melis, M.; Verucchi, G.; Masetti, C.; Coppola, N.; Magni, C.F.; Micheli, V.; Pollicino, T.; Ruggiero, T.; Landonio, S.; Mancon, A.; Starace, M.; De Leonardis, F.; Santopaolo, F.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e49
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Natural HCV resistance is common in Italy and differently associated to genotypes. Issue 1 (16th February 2017)

Authors:
Sorbo, M.C.; Cento, V.; Bertoli, A.; Lenci, I.; Polilli, E.; Masetti, C.; Gianserra, L.; Teti, E.; Biliotti, E.; Magni, C.F.; Aragri, M.; Micheli, V.; Melis, M.; Nicolini, L.A.; Marenco, S.; Calvaruso, V.; Paolucci, S.; Baldanti, F.; Morisco, F.; Siciliano, M.
Journal:
Digestive and liver disease
Issue:
Volume 49:Issue 1(2017)Supplement
Page Start:
e52
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗